ArticleFrontiers in medicine2025
Case Report: Subcapsular hematoma post-transarterial embolization and its laparoscopic resolution.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatic hemangioma (HH) is a common benign liver tumor. Transarterial embolization (TAE) is a widely adopted minimally invasive treatment. Subcapsular hematoma (SCH) is an exceptionally rare and severe complication following TAE, with only sporadic cases reported and no standardized management protocol. Case presentation: A 43-year-old female presented with acute right upper quadrant pain 8 days after an attempted TAE for a caudate lobe HH at another institution, which had been aborted due to unsuccessful vessel cannulation. Upon admission, contrast-enhanced CT revealed a large SCH in the right hepatic lobe alongside the known caudate lobe HH. Her condition rapidly deteriorated, with a significant decline in hemoglobin and signs of hemorrhagic shock, necessitating emergency intervention. She subsequently underwent a simultaneous laparoscopic procedure consisting of evacuation of the massive SCH (approximately 2000 mL) and enucleation of the giant caudate lobe hemangioma. The surgical strategy included a left-sided approach, utilization of the Arantius ligament as a key anatomical landmark, and low central venous pressure (CVP) anesthesia to minimize intraoperative bleeding. Conclusion: This case represents, to our knowledge, the first report of SCH as a complication following hepatic artery angiography or attempted TAE and the only reported case of simultaneous laparoscopic management of both a ruptured SCH and a caudate lobe HH. It highlights that SCH, although rare, can be a life-threatening complication of endovascular procedures. Laparoscopic surgery is a feasible and effective therapeutic option for managing such complex conditions. This report underscores the critical importance of meticulous technique during TAE and vigilant postoperative monitoring to prevent this serious complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.